News

Bain Capital and KKR are among three groups preparing bids for Sapporo Holdings' real estate business, valued at approximately $2.7 billion. Sapporo is selling its real estate hol ...
Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets ...
Seoul – Hyosung Advanced Materials Corp. (HAMC) has confirmed Bain Capital Private Equity (Asia) LLC as the preferred bidder for its steel tire cord business, following a media report suggesting a ...
The three groups preparing to bid are Lone Star and Kenedix, Bain and Tokyu Fudosan, and KKR, PAG and Nomura Real Estate, two ...
Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...
The $139 billion TAMP has hired industry veteran Phil Rogerson, unveils $10 million commitment for strategic expansion in ...
A new startup offering an AI-enabled threat-hunting platform is emerging from stealth today with backing from Bain Capital ...
Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...
Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...
BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...